Verve Ventures is one of Europe’s ten most active venture capital investors. Founded in 2010 in Switzerland, Verve has offices in Zurich, Paris, Berlin and Cambridge and a team of around 40 people. Verve has invested in over 170 science- and technology-driven startups from the Seed stage onward. Through Verve, startups get access to a large network of private and institutional investors that help them win new clients and hire top talent. To join Verve Ventures’ growing community of entrepreneurs and investors, visit verve.vc.
MEGATREND INVEST is a well consolidated provider of capital between investors looking for alternative investments and sustainable start-ups and growth companies seeking capital. Through risk diversification, we provide a high rate of return for investors. MEGATREND INVEST expect companies to conduct a responsible and sustainable business based on 9 leading megatrends in the world (such as health, biotechnology, etc.) and focus investments on sustainable products and solutions based on the sustainable development goals.
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 750 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 180 companies
With a fund size of €400 million, Evonik Venture Capital (EVC) has made 50 investments since 2012, both direct and fund investments. From its offices in Germany, the USA and China, EVC invests in innovative technologies and business models in the area of Nutrition & Care, Smart Materials and Specialty Additives. The investments also support the digitalization and sustainability strategy of Evonik. The scope ranges from early stage to growth stage with an investment volume of up to €15 million per portfolio company.
As a single-family office, Sanner Ventures aims to explore new business areas, to facilitate collaboration and to invest in early-stage technology companies in the area of health and well-being. Sanner Ventures is devoted to products and solutions that help to protect patient health and facilitate better health outcomes.